AI-assisted drug design services based on mechanism research for pharma and research institutions, include but are not limited to: long-term strategic cooperation, fixed number of target cooperative development, one-time transaction, milestone payment.
Partner with pharma companies for deep collaborative in drug development, risk-sharing, and revenue enhancement.
Conduct independent drug design for key targets, retaining full intellectual property rights; Explore various monetization strategies, including in-house development, patent licensing, and collaborative development.
MoMed Biotech relies on globally leading computational biology technology, combined with cutting-edge technologies such as artificial intelligence, computational chemistry, and high-throughput virtual screening, to create an innovative drug molecular design platform. It is committed to providing efficient drug discovery CRO services, improving the efficiency of new drug research and development, and saving industry costs.